Skip to main content

US Autotransfusion Services Market to Reach USD 1,072.1 Million with 6.5% CAGR by 2027; Rising Number of Surgical Procedures to Aid Growth: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, Nov. 12, 2020 (GLOBE NEWSWIRE) — The US autotransfusion services market size is set to gain impetus from the increasing number of surgical procedures occurring in the country. It is, in turn, expected to surge the need for blood transfusion. The study further mentions that the US Autotransfusion Services Market size was USD 838.4 million in 2019 and is projected to reach USD 1,072.1 million by 2027, exhibiting a CAGR of 6.5% during the forecast period. The market for autotransfusion services in the U.S. possesses a large number of small and domestic companies. Most of them are adopting the strategy of mergers and acquisitions to strengthen their positions in the market.Key Players Aim to Adopt Acquisition Strategy to Strengthen Their PositionsSome of the others are trying to bag new awards to gain a competitive edge. Below are two industry developments:January 2020: SpecialtyCare, a provider of allied health and outsourced operating room services based in the U.S. successfully acquired Arizona Perfusion Supply Company, LLC (APS) and Phoenix Perfusion Services, LLC (PPS) to become the largest provider of patient-centered perfusion services to health systems, surgery centers, and hospitals. September 2016: The Pediatric ECMO Program at New York-Presbyterian/Morgan Stanley Children’s Hospital and the Center for Acute Respiratory Failure and Cardiac ECMO Program at New York-Presbyterian/Columbia University were presented the Platinum Level Center of Excellence award.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-autotransfusion-services-market-104196
COVID-19 to Hamper Growth Backed by Cancellation of Various ProceduresThe Minneapolis Heart Institute Foundation states that in the U.S., there was an estimated decline of 40% in ST-elevation myocardial infarction (STEMI) procedures during the first quarter of 2020. The COVID-19 pandemic is the major contributor to this loss because of the cancellation of surgeries, as well as low demand for autotransfusion services. Also, the rising number of strict laws implemented by the government of various countries is compelling people to remain at their homes to prevent transmission. Our high-quality reports would help you find the way towards success.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/u-s-autotransfusion-services-market-104196
Increasing Beneficial Properties to Accelerate DemandAutotransfusion services have numerous benefits. They are capable of removing pre-transfusion inspections related to allogeneic blood. At the same time, they can improve activities of coagulation factors, provide better oxygen transfer, and reduce the risk of infections.As per the Agency for Healthcare Research and Quality (AHRQ) and the American Academy of Orthopedic Surgeons (AAOS), every year, approximately 450,000 hip replacement and 790,000 knee replacement procedures are performed in the U.S. It is set to propel the US Autotransfusion Services Market growth in the coming years.However, autotransfusion services can have multiple side effects ranging from cold sweat and dizziness to vomiting and severe drop in blood pressure. This factor may obstruct the demand for autotransfusion services.
Quick Buy –  US Autotransfusion Services Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104196
Orthopedic Segment to Exhibit High CAGR Fueled by Presence of Multiple CompaniesBased on indication, the orthopedic segment earned 15.8% in terms of the US Autotransfusion Services Market share in 2019. It is anticipated to exhibit a comparatively higher CAGR in the near future on account of the presence of several companies offering autotransfusion services in the country.
A list of all the renowned autotransfusion services providers operating in the U.S. market:Comprehensive Care Services (Michigan, U.S.)SpecialtyCare (Tennessee, U.S.)Keystone Perfusion (Pennsylvania, U.S.)Atlanta Surgical Services Inc. (Atlanta, U.S.)Vivacity Perfusion (Tennessee, U.S.)Carolina Autotransfusion, Inc. (South Carolina, U.S.)CENTRAL VALLEY PERFUSION, INC. (California, U.S.)Other Prominent Players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-autotransfusion-services-market-104196
Table of Contents:IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsNumber of Surgeries Performed in the U.S., by Key Indication, 2019Key Industry Developments – Mergers, Acquisition, and PartnershipsPricing Analysis, By Key Market PlayersImpact of COVID-19 on United States Autotransfusion Services MarketUS Autotransfusion Services Market Analysis, Insights and Forecast, 2016-2027Key Findings / SummaryMarket Analysis, Insights and Forecast – By ApplicationCardiovascularOrthopaedicNeurologyGynaecologyUrologyTraumaOthersMarket Analysis, Insights and Forecast – By End UserHospitalsAmbulatory Surgery CentersCompetitive AnalysisKey Industry DevelopmentsU.S. Market Share Analysis (2019)Company Profiles (Overview, Services, SWOT Analysis, Recent Developments, Strategies, Financials (based on availability))Comprehensive Care ServicesSpecialtyCareKeystone PerfusionAtlanta Surgical Services Inc.Vivacity PerfusionCarolina Autotransfusion, Inc.CENTRAL VALLEY PERFUSION, INC.Strategic Recommendations
TOC Continued….!
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/u-s-autotransfusion-services-market-104196
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companiesDetails in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facilityNumber of procedures and average price of proceduresReplacement rate and pricing of capital equipmentMarket dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunitiesMarket & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:Autotransfusion Devices Market Share & Industry Analysis, By Product Type (Autotransfusion Systems and Consumables & Accessories) By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, and Others) By End User (Hospitals and Specialty Clinics & Others) and Regional Forecast, 2019-2026Home Infusion Therapy Market Share & Covid-19 Impact Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027Blood Group Typing Market Share & Industry Analysis, By Product (Instruments, and Reagents & Kits), By Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-matching Tests, and HLA Typing), By Techniques (Serology Tests, and Molecular Tests), By End User (Hospital-based Laboratories, and Independent Laboratories & Blood Banks), and Regional Forecast, 2020-2027Monoclonal Antibody Therapy Market Share & Industry Analysis, By Type (Human Monoclonal Antibody, Humanized Monoclonal Antibody, Chimeric Monoclonal Antibody, and Murine Monoclonal Antibody), By Application (Cancer, Autoimmune Diseases, and Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027Insulin Pump Market Share & Industry Analysis, By Product Type (Pumps (Tethered Pumps, Patch Pumps, and Others), and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.